A new pill to treat HIV just got approved — and it could shake up a $22 billion market (GILD)

NIAID

• The FDA just approved a new combination of drugs to treat HIV.
• The treatment combines three drugs into one daily pill:  bictegravir, emtricitabine and tenofovir alafenamide.
• The new approval could shake up the $ 22 billion HIV drug market.

---

The FDA just approved a new, once-a-day pill to treat HIV.

The pill, made by Gilead Sciences, contains bictegravir, along with emtricitabine and tenofovir alafenamide, two drugs that are considered the “backbone” of HIV treatments. Of the three treatments contained in the pill, bictegravir is the only totally new element. See the rest of the story at Business Insider

NOW WATCH: CEO of blockchain company Chain on what everyone gets wrong about the technology

See Also:

• A look at the demanding schedule of Elon Musk, who works in 5-minute slots, skips breakfast, and largely avoids emails
• Former SpaceX worker reveals 7 outrageous perks Elon Musk gives employees
• A Gates Foundation-backed startup wants to make daily pills a thing of the past

SEE ALSO: 2 giant drugmakers are racing to make a breakthrough in treating HIV, and there’s $ 22 billion on the line

DON’T MISS: The microbiome has been called the forgotten organ — and it could hold the ‘next paradigm shift in science and medicine’